Earlens is a medical technology company transforming the hearing experience with the only direct sound delivery system.
Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens Contact Hearing Solution, which directly activates natural hearing, delivering the broadest bandwidth available today and superior sound quality. This revolutionary, non-surgical hearing solution uses a small lens to vibrate the eardrum, replicating the natural hearing process. The Earlens Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the Earlens Contact Hearing Solution™ is the world’s first to deliver sound directly to the eardrum.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 22, 2018 | Series D | $87M | 6 | — | — | Detail |
Jun 5, 2017 | Series C | $73M | 1 | — | — | Detail |
Jun 16, 2016 | Series C | $34M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Sightline Healthcare Opportunity | — | Series D |
MS Pace LP | — | Series D |
GDN Holdings | — | Series D |
Baltisches Haus | — | Series D |
ARCH Healthcare Fund | — | Series D |
Relativity Healthcare Partners | — | Series D |
Medtronic | — | Series C |